RNA Q2 2021 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+69.2% YoY

Gross Profit

-$20M-771.0% margin

Operating Income

-$26M-1011.4% margin

Net Income

-$26M-1010.9% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$291M

Total Liabilities

$26M

Stockholders' Equity

$264M

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+69.2%
Gross Profit	-$20M	$2M	-1404.3%
Operating Income	-$26M	-$10M	-154.3%
Net Income	-$26M	-$11M	-149.6%